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Amphibians have been employed enten,~ively to study the anatomy, physiology, bloehernistry, and cell biology of the visual system for decades, 
yet there have been no reports concerning the primary .,,tructure ofarnplub~an w~ual transduet~on components. Thu-,,, we have determined the entire 
nueleot~de ~ q~aenee of frog (Rana ptptetls') rhodopsin eDNA, including a putative transcription start point and poly A tail, by ~¢quen¢~ analysi~ 
of PCR products and mRNA. The open reading frame predicts an op~m of 354 residue, six residues longer than the mammahan rod opsins. 
containing l I potential phosphorylation sites in the C-terminal domain. RNA blot analys~s revealed two transeript~ ofca. 1.7 and 3.1 kb Frog 
thodop~m enlnb~ts ~85% tdent,ty to mammalian rhodopsin at the amino acid level. S~uence analysis of additional components will produce the 
framework from winch a more detailed under~tandrn8 of amph~bmn phototransduetion ca emerge 
Rhodopsin; Frog (Rtma pipiens); Pbotoreceptor; Polymemse cham re,tct~on; RNA .~equencmg, Northern ,tnaly~l~; Transcription start point; Visval 
transduetion 
1. INTRODUCTION 
Rhodopsin,  the visual pigment of  retinal rod photore-  
ceptor cells, consists o f  an M, ,.~ 40 kDa glycoprotein 
(opsin) to which a light-sensitive chromophore  (1 l-cis 
retinaldehyde) is attached (reviewed in [1-4]). It is also 
the most extensively studied and prototype member  o f  
a superfamily of  G-prote in coupled membrane recep- 
tors, which share a common seven t ransmembrane h lix 
domain structure [4,5]. The recent identif ication o f  over 
30 mutat ions in tlae human rhodopsin gene [6-8] in 
well,defined cases o f  autosomal  dominant  retinitis pig. 
mentosa (adRP), a hereditary blinding disease, has 
sparked intense interest in defining the relat ionship o f  
rhodopsin's  tructure to its physiological function in the 
photoreeeptor  ceil. Herein, we report the complete pri- 
mary structure or  rhodopsin from the common leopard 
frog, Rana pipiens, as determined exclusively by RNA 
sequencing and analysis o f  PCR products,  and briefly 
compare our  findings with some of  the known structural 
features o f  rhodopsins t'rotu other ~pecies. 
2. MATERIALS  AND METHODS 
2.1. RN,,I isolation anti eDNA aynthesin 
Fifty retinas were dissected free of pigment epithelium under ice- 
chilled phosphate-buffered sahne from dark-adapted frogb (Rana 
pipiens, Northern; Charles Sullivan Co., Nashwlle, TN), and frozen 
immediatdy in liquid nitrogen. Pol), A* RNA was i~olated irt.~ztly 
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from homotgemred retinal t~ue using the Fast Track mRNA isolation 
kit (lnvitrogen). Priol to syntheqs of the firnt ntrand of eDNA, RNA 
was precipitated al -20°C with I M LiCI and 7 vols. o1' ethanol to 
r~:move r sidual ~odlurn dodecyl sulfate. Synthesis of eDNA was car- 
ned out with 2/tg of retinal RNA and 1/ag of a modified ohgo-dT 
primer [9] u~ing aeDNA s),nthesis kit (Promega). The eDNA was then 
dduted 1.10 w~th water and .~tored at -20°C prior to a~. 
2.20hgonuclt.ot,de ~')'nthe~'ts and PCR 
Ohgonucleotide5 were synthesized wah an Applied Bio~ystem.~ 
Model 391 PCR-Mate DNA bynthe~lzer. The ohgomer~ were depro- 
tected and cleaved from the column in 30% ammonium hydroxide at 
55°C for at least 8-16 h. Ammomttm hydroxide was removed by 
evaporation i  a bpeed-va¢ nd the oht~omer~ were d~szolved ,n water 
PCR was performed in a total volume or 25/.tl, or 400/.tl for prepara- 
tive put po~es, a~ prewously described [10]. The following primers were 
employed: A, 5"-ATGAACGGCACAGAGGGCCCCAA; B, 5'. 
TTCCGGAACTGCATGCTCAC'. C, 5"-CCGCAT(SCGGCCGCA- 
GATCTAGA, D, 5'-CG ATGATCTTATGCAGGTGACACC; E, 5"- 
GCCAGGTAATACTGAGGGTAGTCG (nee Flls. I), in addition 
sequencing primer~ 5'-CTGGCCAGTTCATCTTGCTAAA, 5'- 
CAACCCTGTCATCTACATT, 5'.CTGGACCAGCCAACGAGT- 
GG, 5'-AAATTGCCCTGTGGTCCTTGG. and 5'.CCTTG'I'rA. 
AGGCAAAGAATGCCG were also u'~ed. 
2.3. DNA attd RNA vequeacing 
DNA sequencing of amplified PCR products was earned oat as 
previously described [10] RNA sequencing was perlbrmed using 6/~g 
or frot~ retina poly A* RNA and an internal frog op~in primer in a 
reverse transcription reaction as de~ribed [11]. 
2.4. RNA blot analysts 
One to 2/.tg ofpoly A" RNA was electrophorescd in a 0.8,% agaro~e, 
formaldd~yde-eontaining gel, transferred tonitrocellulose membranes 
[12]. and hybridized [111 with a radiolabelcd frog PCR product, PCR- 
BC Wig 1). Two initial washes were carried out in 2 x SSC (! × SSC 
= 0.15 M NaCI. 0 015 M Na citrate) at room temperature. Four 20 
rain high-stringency washes were perforaled at ~°C m o l × SSC prior 
to autorediography without intennifying ~creens. 
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Fig l. Amphfieatton and RNA sequencing or frog rhodopsm Shown at the top is a schematic repre6entabon era portion ormou~e opsin eDNA 
Primers A and B were designed from the mou~e rhodopsin ~equence [9]. Prlmer~ D and E were designed from the bequenees determined from PCR 
products, PCR-AD, and PCR-BC. Inclusion of the revults from RNA ~equeneing with P~ irner E results in the full length opsin mRNA designated 
FOPS. 
2.5. Computer attaly~t~ {fDNA sequetwes 
Anal~,~ib wa~ performed on microcomputers using M~erogeme 
(Beckman) or on a minicomputer for multtple ueqttence alignment~ 
and database Beaiellcs through the Molecular Biology lnfoHnation 
Reuource (Department of Cell Biology, Baylor College of Medicine) 
3. RESULTS AND DISCUSSION 
3.1. PCR amplificatton offrog opsin 
We developed a general scheme for PCR amplifica- 
tion or the entire frog opsin mRNA that should be 
applicable for any moderate to high abundance tran- 
seript in which sequence information is available from 
another species. The relatively high degree of sequence 
conservation among the opsins from diverse species [3], 
while not essential for success, greatly simplified the use 
of cross-species PCR amplification. As shown in Fig. 1, 
in the first PCR reaction a primer specific for mouse 
opsin eDNA sequence (B) was used in conjunction with 
a universal 3' end primer (C) [9] and frog first strand 
eDNA as a template, allowing amplification of frog 
opsin-speeilic sequence (PCR-BC) from tl~e 3' end of the 
mouse opsin primer to the poly A tail. The sequence 
determined from product PCR-BC was then used to 
construct a frog opsin-speeifie antisense primer repre- 
senting the C-terminal region (D). This primer was used 
in a PCR reaction with a primer representing the N- 
terminal region of mouse opsin (A), yielding a PCR 
product covering the majority of the protein coding 
region (PCR-AD). A frog opsin-speeific antisense 
primer (E) was synthesized according to the sequence 
determined near the 5' end of product PCR-AD for 
direct sequencing of frog poly A+ RNA, allowing deter- 
mination of sequence up to a putative transcription start 
point of the frog opsin gone. 
3.2. RNA blot analys~ 
Since several rhodopsin genes and cDNAs have been 
anab, zed in the laboratory where the PCR was done, 
RNA blot analysis was used to confirm the origin of the 
PCR amplified material. Previously we showed that two 
transcripts of 3.0 and 1.7 kb are identified in frog retinal 
RNA using a mouse opsin eDNA probe [9]. A blot 
104 
containing fish and chicken retinal RNAs was probed 
since the chicken [20] and frog opsin sequences are more 
closely related, and tile fish opsin sequence has been 
amplified in the lab, but not yet sequenced. As shown 
in Fig. 2, using high stringency washing conditions, only 
RNA from fi'og retina showed hybridization to RNAs 
of 1.7 and 3.1 kb; lanes containing RNA from frog liver, 
chicken retina, or fish retina exhibited no hybridization 
signal, even after prolonged exposure times (not 
shown). We had also previously shown that the multiple 
mouse opsin transcripts identified by RNA blot analysis 
result from the use of alternate poly A sites in the 3' end 
of the mouse opsin gene [9]. Since only a single 5' end 
is indicated by RNA sequence analysis, it is likely that 
the frog opsin gene also produces its two transcripts by 
the same mechanism. The length of the sequence shown 
in Fig. 2 is consistent with it representing the shorter 1.7 
kb mRNA species. 
3.3. Primary structure of.frog Ol)ShZ 
The sequences determined from the overlapping PCR 
products, PCR-AD, PCR-BC, and from the RNA se- 
quencing with primer E, allowed a composite full length 
frog opsin sequence (see Fig. 1, FOPS) to be constructed 
(Fig. 3). The 1,730 nt sequence consists of 105, 563, and 
1,062 residues of 5', 3', and protein coding segments, 
respectively. The open reading frame predicts a protein 
of 354 amino acids; six residues longer than the mam- 
malian rod opsins sequenced to date, all of which are 
348 residues in length. Tile additional residues are 
found in the C-terminal domain resulting in 11 potential 
phosphorylation sites, as opposed to the 6 or 7 found 
in mammalian opsins. With the exception of bovine 
[13,14] and ovine [15], which have 7, all other mammal- 
ian, Drosophila [16,17], and blowfly [18] opsins have 6 
potential phosphorylation sites, while op~ins from lam- 
prey [19] and ehieken [20] have 11 and 10 sites, respec- 
tively, in the C-terminal domain (see Fig. 3A). Addi- 
tional phosphorylation sites may explain the faster rate 
of phosphorylation suggested for frog rhodopsin as 
compared to bovine [21]. 
As with other known vertebrate rhodopsins, frog rho- 
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Fig. 2. RNA blot analysm of frog rhodopsm. Approximately 2 ~tg of 
poly A ÷ from each tmsue was electrophore~ed onto a formaldehyde 
containing ;lgalob¢ gel. After blotting to nitrocellulose the blot wa~ 
probed with a radiolabeled frog opsm PCR product representing the 
3' end and ~ashed at lugh stringency. Lanes I-5 contain frog retina, 
flog liver, ~hieken livei, cl~icken retina, and fi~h rct,na RNAs. reM~cc- 
tlvely. 
dopsin contains two N-glycosylation consensus se- 
quences near the N-terminus (Fig. 4A). Within the first 
17 restdues of the N-terminal domain including the gly- 
cosylation sites~ there is 88% identity of the frog se- 
quence with that of bovine and ovine rhodopsins, and 
82% with the rhodopsin sequences of human [22], 
chicken and lamprey. The first N-glycosylation site 
(Asn-~-Gly3-Thr 4) is identical in all vertebrate species, 
while the second site (Asn~-Lysl~-Thr ~7) is identical in 
most species examined thus far, except human and 
mouse, where Lys ~6 is replaced by an aliphatie residue 
(Ala or Val, respectively). This is cons[slent with the 
Asn-Xaa-Ser/Thr consensus sequence where Xaa can be 
any residue xcept proline [23]. The presence and struc- 
tures of oligosaccharides at both glycosylation sites of 
frog rhodopsin have been confirmed recently [24]. 
The C-terminal domain of frog rhodopsin also con- 
tains two putative adjacent sites for palmitoylation 
(Cys ~'~ and Cys 3-~3, Fig. 4B), as found in all other rho- 
dopsins sequenced thus far. The presence of a eo- 
valently attached palmitoyl moiety has been rigorously 
demonstrated for bovine rhodopsin [25,26]. It is pre- 
sumed that the palmitoyl moieties insert into the lipid 
bilayer of the rod outer segment disc membrane, 
thereby anchoring a proximal region of the C-terminal 
domam to the membrane. The additional loop that 
would be predicted to exist (see Fig. 5) has been shown 
to be involved in interaction with rhodopsin's G-pro- 
tein, transdacin [27]. The C-terminal residue (Ale ~,  
Fig. 2) is also found at the C-terminus of all other 
rhodopsins thus far analyzed, including squid and octo- 
pus rhodopsins [28,29], which have long insertions near 
their C-termini (see Fig. 3). It is possible that the C- 
ACCTCTTCTGG~CATA`r~GTTTTT~TTGGG~TTCCTGAGA~GAGG~AG/Lr~CACAGAAGTGGTTTCTGAGcCGAGGGGGGT~AO~TT~GCTGccA~T~c~cA~-~2~ 
M N G T % - 5  
GGTC~TTTTTA~TC~AT~T~T~C~GA~TGGGGTAGTA~G~GCCC~?TCGACTAC~CTCAGTATTACCTGGCAGAG~TGG~GTA~TA~GGC~CTA~TGTTC-24~ 
G P N F W Z P M S N K T G V V R S P ~ D Y P 0 Y Y L A E P W K Y S V L A A Y M F -45 
TT~CT~TCCTCCTCGGTTTA~C~TC~CTTTATGACCC~GTATGTCA~ATCCAG~AC~AGCTCCG~CACCCTT~CTACATC~G~T~TCTTGcCGTTTG~TC-36~ 
L L X L L G L P I N P M T L Y V T I Q ~ K K L R T P L N Y I L L N L G V C N ~ F -85 
ATGGT~TGT~TGGATT~CCAT~ACGATGTA~A~T~CT~ATG~TA~TTTGTATT~G~GA~TG~TTG~TA~TTTG~GG~T~TTc~TAc~TTGGTG~TG~TT~C~TT-48~ 
M V L C G F T I T M Y T S L ~ ~ Y F V F G Q T G C Y F E G F F A T L G G E I A L 125 
TGGT~TGGTGGTGTTG~ATT~G~GATAcATTGT~GT~TG~G~C~AT~GC~TTTCCGATTTGGT~AG~C~TGC~TGATG~GTAG~TT~T~T~TGGCC~G-6O~ 
W S L V V L A I ~ R Y i V V C K P M S N ? R F G E N I I  A M M G V A F T H I M A L -165 
GCTTG~G~TGTTCCTCCACTCTTCGGCTGGT~AGATA~TCC~TG~G~TGCAGTGCT~TGTGGAGTTGA~TA~TA~A~TCT~G~~TGAGTc~T~TC-~2~ 
A C A V P P L F G W S R Y ~ P E G M ~ C S C G V D Y Y T L ~ P E V N N ~ S ~ V X -205 
TA~TGT~C~TTGTCCACTT~CTc~TC~cT~T~T~T~TTTCCTT~G~TA~GGA~TGGT~TG~CTGT~AGA~CCTGCD~C~G~T~A~C~AG~G-84~ 
Y M F V V It F L I P L I I ~ S ~ C X G B L V U T V K E A A A Q Q Q E S A T T Q E -245 
G~GA~G~T~A~G~TGG~TAZCATTATGGT~A~TT~TCCT~TTTGCTG~GTCC~A~GC~TATGTTGCATT~A~T~T~CC~C~CTCA~e~C~G-9~ 
A E ~ ~ V T R M V ~ ~ M V ~ ? F L I C H V P Y A Y V A F Y : F T ~ Q G S ~ ~ ~ ~ -285 
A~`~TGACCGTGC~GCTTTCTTTGCC~G~TCTG~TCTA~CC~TGTCA~TA~ATTATG~TG~A~T~cGT~A~TGCATGAT~c~A~CTGT~GT~-~8~ 
I F M T V P A F F A K S S A I ~ ~ P V I • X M L ~ K Q ~ E ~ C M I ~ T L C C G K -325 
AATC~CT~GGAGATGAcGATG~T~T~TG~TG~TTCc~ACA~Gc~c~TcTGT~T~TA~GCCAGGTGT~A~G~T~GAT~TC~C~GTGT~-~2~ 
N p ~ G D D D A S S A A T S ~ T E A T S V S T S ~ V S P A * -354 
CcT~TcAGCTC~GeTA~C~TCTT~GCAT~TCC~T~AAA~TGC~CTATAC~ATAAATAC~TG~CATATTTT~C~G~G~~¢~AA-~2~ 
c~TC~TG~T~CCGA~T~ATT~%ATT~TTT~T~GAT~G~ATTTATGG~A~GTTCGTTT~C~~.~G~TTT~~T-~44~ 
AC~C~TG~CCGA~TA~TGTT~CCTG~CGCCTT~G~T~%AG~GA~G~GA~TTT~G~-AAAT~TA~TC~A~C~TT~TG~ATAC~TG-~56~ 
GCGCA~GAGTGT~TG~GTT~TCTTGCT~TTTGT~qT~T~ATAC~TGGAGG~TTTTTTGT~TA~GTTATAAAAA~GTTTT~ATTTAT~TG~GGGG~G-~6~ 
ACAGCCCCTCTACCCCGGP~5~CGGC~CTTGGCA~%2~ n - i~0 
Fig. 3. Nueleotlde and predicted amino acid sequence o~' frog rhodopsin. The complete nueleotide s quence of frog rhodopsm is shown. In-frame 
stop codoas that delimit he open reading frame are marked by asterisks The translation i itiation eodon lr ~nown i  boldface. Nacleotid¢ and 
amino acid numbering are shown to the right of the sequence. A poly A site (AATAAA) in d~e 3'-untranslated r slon is underlined. 
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FROG 
CHICKEN 
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MOUSE 
BOVINE 
OVINE 
LAMPREY 
l v ~ 17 
~NGTKG~ K~Z P~NK~ 
NHG~KGO DFYVPNf lNK~ 
~GT~G~ NP~YPF~HA~ 
~HGT~GYNF~VPF  ~HV~ 
NRGTBG¥ N~VPFf lNK~ 
NNGTZGDNF~VPF ~HKT 
# ~ t t W  j ~ S j N j t ~  
B. 
FROG 
LAMPREY 
I'IUMAI~ 
tIC)USE 
BOVINE 
OVINE 
GHICKEN 
~ C C U ~ . e r G D D . h B = X A ~ Z A T ~ V B ~ . Q V . e A  
Fig 4. Comparison of N- and C-terminal domains of rhodopsm in several ~pecies. (A) Sequence omparison r the N.termlnal dommn. 
Glycosylation ~ites are marked by arrow~ (B) Sequence ompat,~on 1"the C.terminal domain. Asterisks indicate Mentiti~s, p~liod~ denote 
conserved amino acid d,fferenees. Gaps (-) were introduced to optimize alignment~ The sequence~ shown were downloaded from the PIR database 
as referenced id the text. 
terminal Ala is required for proper insertion and orien- 
tation of rhodopsm in the membra,ae. 
Several other residues that have been shown to be 
essential for rhodopsin function in mammals are also 
maintained in frog rhodopsin (Fig. 5). Two h~stidine 
residues (His 6~, His t~-') required for the shift from the 
metarhodopsin I isomcrization state to the metarho- 
dopsin I1 state [1.30] are maintained in the frog se- 
quence. Deletion analysis of cysteine residues revealed 
two c~'steines (Cys j)°, Cys )'~7) that form a disulfide 
bridge required for normal structure of bovine rhodop- 
sin [31,32], both of which are maintained in the frog 
rhodopsin sequence. Seven residues (Phe ~,  Ale ttT, 
Glu m, Trp L'°, SerJ-'r0 Trp-'~0 Tyfl ~s) thus far have been 
shown to interact with the chromophore [1--4] (see Fig. 
5) in the retinal binding pocket, all of which are main- 
tained in the fro8 rhodopsin primary structure. Addi- 
tionally, charged residues, Gltt TM and Arg '~, are pres- 
ent at the beginning of the second cytoplasmic loop 02, 
Fig. 5) which are necessary for transducin binding. 
G!u tj~ and His -~ which are the counterion of the $chiff 
base and a possible major site of metarhodopsin I/ 
metarhodopsin 11 modulation, respectively, are also 
conserved. 
3.4. Predicted topography of fi'og opsin 
Fig. 3 shows a predicted topographical model for frog 
rhodopsin as it would be arranged in the rod outer 
segment disc membrane. Many of the residues hown to 
be essential for structure and function, non-conserved 
differences incomparison to other opsin sequences, and 
residues that arc implicated as causative of adRP (see 
below) are shown. This model is strictly analogous to 
topographical models previously proposed by other in- 
vestigators [33-35], based upon data obtained by chem- 
ical modification, protease and transglataminase us- 
ceptibility, antibody binding, and theoretical physical- 
chemical considerations. 
3.5. Potential application to human disease studies 
Using the candidate gene approach [11]~ point muta- 
tions or small deletions in the human rhodopsin gene 
have been shown to segregate with adRP in several 
families tudied throughout the world [6-8]. The altered 
residues identified are shown in Fig. 5. Overall, frog and 
human rhodopsin display 85% identity and another 
10% similarity at the amino acid level. All but two 
(Gly ~'~, Phe 22° in human rhodopsin) of the residues 
Ibund to be mutated in patients with adRP are identical 
in the frog rhodopsin sequence, consistent with the es- 
sential nature of these residues. Furthermore, the ma- 
jority of the residues are also identical in rhodopsins of 
more distantly related species uch as squid, octopus, 
Deosophila nd blowfly. The compilation of sequences 
from diverse species allows residues that may be essen- 
tial for function to be identified, and the search for 
further mutations to be initially concentrated in these 
regions. This type of sequence comparison may be espe- 
cially useful for the application of the candidate gene 
approach to much larger genes with more complex in- 
tron/exon organizations (i.e. rod phosphodiesterase ~x 
and/J subunit genes) to focus on regions where signifi- 
cant sequence differences might be found. 
These results represent the first molecular description 
of a frog phototransduction cascade component. Mo- 
lecular analysis of other essential visual transduction 
genes in frog may yield the information ecessary to 
explain the differences observed in biochemical and 
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Fig. 5 Topograph~l model of the secondary structure of frog rhodopsin. The predicted topography (ba:~d on [3]) of frog rhodopsin from the 
anterior portion of a disc membrane is shown The N-terminus, as well as loops et, e, and ¢3, are within the di~e lumen, seven traasmembrane 
domains (i-¥1I) are present, anti loops i~, i:, i~, i.~, and the C-terminal poruon are located in the photorgceptor e]/topl~m. Boxed residues indicate 
non-eonserw~l sequence differences m comparison with mammalian, chicken, and lamprey opsm sequences. Encircled residues are known to b~ 
important for rhodopsin function as described in the tent. Residues within a diamond ar~ implicated as mutations responsible for certain forms 
of human adRP Only mutations involving single amino acid diflbrences are shown. Arrows above the C-terminal sequence mark the positions 
of i'c~tenti',t phosphorylation ~tes at the C-terminus; boxes below show the relative position of phosphorylatmn sites in human rhodopsin. 
electroph:/siologieal properties of phototransduction in 
mammals and amphibians, leading to a better under- 
standing of visual transdaction. 
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